Catalyst Wire Dossier Catalyst Wire Dossier

HEC585 Tablets

· Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEC585 Tablets, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF [Phase 3]

See pricing